<?xml version="1.0" encoding="UTF-8"?>
<p>The current technology platform used by the majority of POCT integrates nucleic acid extraction, amplification and detection on a microfluidic chip that reduces detection complexity (
 <xref rid="b88-etm-0-0-09142" ref-type="bibr">88</xref>). Systems presently used include GeneXpert from Danaher Corporation, as well as FilmArray from BioMÃ©rieux and Liat from Hoffmann-La Roche. Numerous domestic companies have developed nucleic acid POCT detection instruments and supporting detection reagents (
 <xref rid="b66-etm-0-0-09142" ref-type="bibr">66</xref>). The 2019-nCoV molecular cassette fluorescent PCR detection method launched by Transview Life can complete the detection of 4 samples in 1-1.5 h. Additionally, Orion BioScience, Inc. has completed the development of a new 2019-nCoV nucleic acid detection kit, which can detect 12 samples at a time (
 <xref rid="b66-etm-0-0-09142" ref-type="bibr">66</xref>).
</p>
